Protein Drugs-Global Market Status and Trend Report 2013-2023
Report Summary
Protein Drugs-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Protein Drugs industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Protein Drugs 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Protein Drugs worldwide, with company and product introduction, position in the Protein Drugs market
Market status and development trend of Protein Drugs by types and applications
Cost and profit status of Protein Drugs, and marketing status
Market growth drivers and challenges
The report segments the global Protein Drugs market as:
Global Protein Drugs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Protein Drugs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Antibody Drugs
Peptide Hormones
Blood Products
Enzymes
Global Protein Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
AIDS
Cancer
Hepatitis
Diabetes
Others
Global Protein Drugs Market: Manufacturers Segment Analysis (Company and Product introduction, Protein Drugs Sales Volume, Revenue, Price and Gross Margin):
Eli Lilly
Abbott Laboratories
UCB Group
Schering-Plough Corporation
Genentech
Johnson＆Johnson
Bristol-Myers Squibb
Novo Nordisk
Biogen Idec
Dendreon Corporation
Amgen
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Protein Drugs-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Protein Drugs industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Protein Drugs 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Protein Drugs worldwide, with company and product introduction, position in the Protein Drugs market
Market status and development trend of Protein Drugs by types and applications
Cost and profit status of Protein Drugs, and marketing status
Market growth drivers and challenges
The report segments the global Protein Drugs market as:
Global Protein Drugs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Protein Drugs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Antibody Drugs
Peptide Hormones
Blood Products
Enzymes
Global Protein Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
AIDS
Cancer
Hepatitis
Diabetes
Others
Global Protein Drugs Market: Manufacturers Segment Analysis (Company and Product introduction, Protein Drugs Sales Volume, Revenue, Price and Gross Margin):
Eli Lilly
Abbott Laboratories
UCB Group
Schering-Plough Corporation
Genentech
Johnson＆Johnson
Bristol-Myers Squibb
Novo Nordisk
Biogen Idec
Dendreon Corporation
Amgen
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PROTEIN DRUGS
1.1 Definition of Protein Drugs in This Report
1.2 Commercial Types of Protein Drugs
1.2.1 Antibody Drugs
1.2.2 Peptide Hormones
1.2.3 Blood Products
1.2.4 Enzymes
1.3 Downstream Application of Protein Drugs
1.3.1 AIDS
1.3.2 Cancer
1.3.3 Hepatitis
1.3.4 Diabetes
1.3.5 Others
1.4 Development History of Protein Drugs
1.5 Market Status and Trend of Protein Drugs 2013-2023
1.5.1 Global Protein Drugs Market Status and Trend 2013-2023
1.5.2 Regional Protein Drugs Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Protein Drugs 2013-2017
2.2 Production Market of Protein Drugs by Regions
2.2.1 Production Volume of Protein Drugs by Regions
2.2.2 Production Value of Protein Drugs by Regions
2.3 Demand Market of Protein Drugs by Regions
2.4 Production and Demand Status of Protein Drugs by Regions
2.4.1 Production and Demand Status of Protein Drugs by Regions 2013-2017
2.4.2 Import and Export Status of Protein Drugs by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Protein Drugs by Types
3.2 Production Value of Protein Drugs by Types
3.3 Market Forecast of Protein Drugs by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Protein Drugs by Downstream Industry
4.2 Market Forecast of Protein Drugs by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PROTEIN DRUGS
5.1 Global Economy Situation and Trend Overview
5.2 Protein Drugs Downstream Industry Situation and Trend Overview
CHAPTER 6 PROTEIN DRUGS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Protein Drugs by Major Manufacturers
6.2 Production Value of Protein Drugs by Major Manufacturers
6.3 Basic Information of Protein Drugs by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Protein Drugs Major Manufacturer
6.3.2 Employees and Revenue Level of Protein Drugs Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PROTEIN DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Eli Lilly
7.1.1 Company profile
7.1.2 Representative Protein Drugs Product
7.1.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Eli Lilly
7.2 Abbott Laboratories
7.2.1 Company profile
7.2.2 Representative Protein Drugs Product
7.2.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.3 UCB Group
7.3.1 Company profile
7.3.2 Representative Protein Drugs Product
7.3.3 Protein Drugs Sales, Revenue, Price and Gross Margin of UCB Group
7.4 Schering-Plough Corporation
7.4.1 Company profile
7.4.2 Representative Protein Drugs Product
7.4.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Schering-Plough Corporation
7.5 Genentech
7.5.1 Company profile
7.5.2 Representative Protein Drugs Product
7.5.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Genentech
7.6 Johnson＆Johnson
7.6.1 Company profile
7.6.2 Representative Protein Drugs Product
7.6.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Johnson＆Johnson
7.7 Bristol-Myers Squibb
7.7.1 Company profile
7.7.2 Representative Protein Drugs Product
7.7.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb
7.8 Novo Nordisk
7.8.1 Company profile
7.8.2 Representative Protein Drugs Product
7.8.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Novo Nordisk
7.9 Biogen Idec
7.9.1 Company profile
7.9.2 Representative Protein Drugs Product
7.9.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Biogen Idec
7.10 Dendreon Corporation
7.10.1 Company profile
7.10.2 Representative Protein Drugs Product
7.10.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Dendreon Corporation
7.11 Amgen
7.11.1 Company profile
7.11.2 Representative Protein Drugs Product
7.11.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Amgen
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PROTEIN DRUGS
8.1 Industry Chain of Protein Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PROTEIN DRUGS
9.1 Cost Structure Analysis of Protein Drugs
9.2 Raw Materials Cost Analysis of Protein Drugs
9.3 Labor Cost Analysis of Protein Drugs
9.4 Manufacturing Expenses Analysis of Protein Drugs
CHAPTER 10 MARKETING STATUS ANALYSIS OF PROTEIN DRUGS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Protein Drugs in This Report
1.2 Commercial Types of Protein Drugs
1.2.1 Antibody Drugs
1.2.2 Peptide Hormones
1.2.3 Blood Products
1.2.4 Enzymes
1.3 Downstream Application of Protein Drugs
1.3.1 AIDS
1.3.2 Cancer
1.3.3 Hepatitis
1.3.4 Diabetes
1.3.5 Others
1.4 Development History of Protein Drugs
1.5 Market Status and Trend of Protein Drugs 2013-2023
1.5.1 Global Protein Drugs Market Status and Trend 2013-2023
1.5.2 Regional Protein Drugs Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Protein Drugs 2013-2017
2.2 Production Market of Protein Drugs by Regions
2.2.1 Production Volume of Protein Drugs by Regions
2.2.2 Production Value of Protein Drugs by Regions
2.3 Demand Market of Protein Drugs by Regions
2.4 Production and Demand Status of Protein Drugs by Regions
2.4.1 Production and Demand Status of Protein Drugs by Regions 2013-2017
2.4.2 Import and Export Status of Protein Drugs by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Protein Drugs by Types
3.2 Production Value of Protein Drugs by Types
3.3 Market Forecast of Protein Drugs by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Protein Drugs by Downstream Industry
4.2 Market Forecast of Protein Drugs by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PROTEIN DRUGS
5.1 Global Economy Situation and Trend Overview
5.2 Protein Drugs Downstream Industry Situation and Trend Overview
CHAPTER 6 PROTEIN DRUGS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Protein Drugs by Major Manufacturers
6.2 Production Value of Protein Drugs by Major Manufacturers
6.3 Basic Information of Protein Drugs by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Protein Drugs Major Manufacturer
6.3.2 Employees and Revenue Level of Protein Drugs Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PROTEIN DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Eli Lilly
7.1.1 Company profile
7.1.2 Representative Protein Drugs Product
7.1.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Eli Lilly
7.2 Abbott Laboratories
7.2.1 Company profile
7.2.2 Representative Protein Drugs Product
7.2.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.3 UCB Group
7.3.1 Company profile
7.3.2 Representative Protein Drugs Product
7.3.3 Protein Drugs Sales, Revenue, Price and Gross Margin of UCB Group
7.4 Schering-Plough Corporation
7.4.1 Company profile
7.4.2 Representative Protein Drugs Product
7.4.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Schering-Plough Corporation
7.5 Genentech
7.5.1 Company profile
7.5.2 Representative Protein Drugs Product
7.5.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Genentech
7.6 Johnson＆Johnson
7.6.1 Company profile
7.6.2 Representative Protein Drugs Product
7.6.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Johnson＆Johnson
7.7 Bristol-Myers Squibb
7.7.1 Company profile
7.7.2 Representative Protein Drugs Product
7.7.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb
7.8 Novo Nordisk
7.8.1 Company profile
7.8.2 Representative Protein Drugs Product
7.8.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Novo Nordisk
7.9 Biogen Idec
7.9.1 Company profile
7.9.2 Representative Protein Drugs Product
7.9.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Biogen Idec
7.10 Dendreon Corporation
7.10.1 Company profile
7.10.2 Representative Protein Drugs Product
7.10.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Dendreon Corporation
7.11 Amgen
7.11.1 Company profile
7.11.2 Representative Protein Drugs Product
7.11.3 Protein Drugs Sales, Revenue, Price and Gross Margin of Amgen
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PROTEIN DRUGS
8.1 Industry Chain of Protein Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PROTEIN DRUGS
9.1 Cost Structure Analysis of Protein Drugs
9.2 Raw Materials Cost Analysis of Protein Drugs
9.3 Labor Cost Analysis of Protein Drugs
9.4 Manufacturing Expenses Analysis of Protein Drugs
CHAPTER 10 MARKETING STATUS ANALYSIS OF PROTEIN DRUGS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
